Ledger.Open graph →

SEC Form D · filed November 5, 2025

Osteal Therapeutics, Inc

Offering

$26.7M

Sold

$15.6M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

DALLAS, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

David Cash · DALLAS, TXDirector Brydon Cotter · Vancovuer, British Columbia, CanadaDirector Darcy Cavanaugh · Vancouver, British Columbia, CanadaDirector Judson Cooper · DALLAS, TXDirector Erik Oros · Baltimore, MDDirector Rushu Luo · DALLAS, TXDirector Deborah J. Cotter · Vancouver, British Columbia, CanadaDirector David Thompson · DALLAS, TXExec · Director Lisa Merage · Newport Beach, CADirector Justin J. Foo · Vancouver, British Columbia, CanadaDirector Biren Mehta · DALLAS, TXDirector Brian De Beaubien · DALLAS, TXExec · Director Judson Cooper · DALLAS, TXDirector Douglas Kohrs · DALLAS, TXDirector Knox J. Henderson · Vancouver, British Columbia, CanadaExec · Director Erik Oros · DALLAS, TXDirector Ryan Lewis · Vancouver, British Columbia, CanadaExec · Director Douglas Kohrs · DALLAS, TXDirector Sonal Patel · DALLAS, TXDirector Martin Sands · DALLAS, TXDirector Biren Mehta · DALLAS, TXDirector Rushu Luo · DALLAS, TXDirector David Cash · DALLAS, TXDirector Martin Sands · DALLAS, TXDirector Brian De Beaubien · DALLAS, TXExec · Director David Thompson · DALLAS, TXExec · Director Sonal Patel · DALLAS, TXDirector Sean Wagner · New York, NYDirector Fred Brown · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗